WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004100875) BENZIMIDAZOLES, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/100875    International Application No.:    PCT/US2004/013874
Publication Date: 25.11.2004 International Filing Date: 05.05.2004
IPC:
A61K 31/415 (2006.01), C07D 235/04 (2006.01)
Applicants: MERCK & CO., INC. [US/US]; 126 East Lincoln Avenue, Rahway, New Jersey 07065-0907 (US) (For All Designated States Except US).
PARMEE, Emma, R. [GB/US]; (US) (For US Only).
KIM, Ronald, M. [US/US]; (US) (For US Only).
LIANG, Rui [US/US]; (US) (For US Only).
CHANG, Jiang [US/US]; (US) (For US Only).
ROUSE, Elizabeth Ashley [US/US]; (US) (For US Only).
CHAPMAN, Kevin, T. [US/US]; (US) (For US Only)
Inventors: PARMEE, Emma, R.; (US).
KIM, Ronald, M.; (US).
LIANG, Rui; (US).
CHANG, Jiang; (US).
ROUSE, Elizabeth Ashley; (US).
CHAPMAN, Kevin, T.; (US)
Common
Representative:
MERCK & CO., INC.; 126 East Lincoln Avenue, Rahway, NJ 07065-0907 (US)
Priority Data:
60/469,332 09.05.2003 US
Title (EN) BENZIMIDAZOLES, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE
(FR) BENZIMIDAZOLES, COMPOSITIONS CONTENANT LESDITS COMPOSES ET METHODES D'UTILISATION
Abstract: front page image
(EN)The present invention relates to substituted benzimidazoles, compositions containing such compounds and methods of treatment The compounds are glucagon receptor antagonists and thus are useful for . treating, preventing or delaying the onset of type 2 diabetes mellitus
(FR)La présente invention concerne des benzimidazoles substitués, des compositions contenant lesdits composés, et des méthodes de traitement. Ces composés sont des antagonistes du récepteur de glucagon et peuvent ainsi traiter, prévenir ou retarder l'apparition du diabète sucré de type 2.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)